CHD1L as a potent anti-apoptotic and pro-proliferative factor, CHD1L overexpression is correlated with the increase of chemotherapy resistance in myeloma [6], NSCLC [66] and ESCC [67]. This evidence concerns the gene CHD1L and non-small cell lung carcinoma.